Location notice: Etobicoke hours changed Sept. 10; the clinic is now closed Fridays.
View hoursBUPRENORPHINE / NALOXONE
Learn how physician-led Suboxone treatment for opioid use disorder works at TSCP, including assessment, ongoing monitoring and integrated pharmacy support.
Answer first
Suboxone combines buprenorphine and naloxone and is used to treat opioid use disorder. A TSCP physician determines whether this option is appropriate based on clinical needs and treatment history.
Opioid use disorder
Buprenorphine is a partial opioid agonist that can reduce withdrawal symptoms and cravings. Naloxone is included in the combination product. Treatment initiation and follow-up should be directed by a qualified clinician.
A medical assessment and review of current opioid use and health history.
A clinician-led discussion about whether buprenorphine/naloxone is appropriate.
Monitoring and follow-up rather than a one-size-fits-all schedule.
Pharmacy coordination through TSCP's integrated clinic-and-pharmacy model where available.
Integrated care
TSCP's clinic-and-pharmacy model helps keep prescribing, dispensing and pharmacist support connected when this medication is prescribed and available through the location.
Related care
TSCP treats opioid use disorder through physician-led assessment and opioid agonist treatment when clinically appropriate. Medication options can include Methadone, Suboxone or Kadian/SROM, with ongoing medical and pharmacy follow-up.
Explore programTSCP can assess and treat opioid use disorder related to fentanyl. A physician reviews the person's opioid use, health risks, previous treatment and goals before deciding whether Methadone, Suboxone or Kadian/SROM may be appropriate.
Explore programHeroin use can lead to opioid use disorder. TSCP provides medical assessment and can offer opioid agonist treatment when clinically appropriate, with medication selection based on individual clinical needs.
Explore programTSCP can assess problematic oxycodone use and determine whether it represents physical dependence, opioid use disorder or another clinical concern. If opioid use disorder is diagnosed, opioid agonist treatment may be considered when appropriate.
Explore programCommon questions
No. A clinician determines whether a medication is appropriate after reviewing your diagnosis, health history, current substance use and prior treatment.
Treatment duration varies. Ongoing follow-up is individualized and should not be stopped or changed without guidance from the treating clinician.
TSCP uses an integrated clinic-and-pharmacy model. Confirm medication availability and the pharmacy workflow with the location involved in your care.
Editorial transparency
Prepared by the TSCP editorial team using Canadian public-health and clinical sources. A named medical reviewer is not displayed until TSCP confirms the reviewer and credentials.
Content updated: 2026-09-10
Four GTA clinics
TSCP clinic
Clinic and integrated pharmacy support. Confirm treatment availability for your specific plan with the location.
TSCP clinic
Clinic and integrated pharmacy support. Confirm treatment availability for your specific plan with the location.
TSCP clinic
Clinic and integrated pharmacy support. Confirm treatment availability for your specific plan with the location.
TSCP clinic
Clinic and integrated pharmacy support. Confirm treatment availability for your specific plan with the location.
